Calif., Feb. 22,
2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a
leading synthetic biotechnology company accelerating the world's
transition to sustainable consumption through its Lab-to-Market™
technology platform today announced that it will issue its
financial results for the fourth quarter and full year ended
December 31, 2021, on the morning of
Tuesday, March 1, 2022, prior to the
opening of the financial markets.
The company will hold a conference call and webcast at
6:00 a.m. Pacific Time (9:00 a.m. Eastern Time), during which,
John Melo, President and Chief
Executive Officer, and Han
Kieftenbeld, Chief Financial Officer, will discuss Amyris'
financial results and provide an update on the company's business.
Participants may access the live webcast on Amyris' Investor
Relations website, where it will be archived for 90 days. The live
call can be accessed by dialing (844) 850-0551 (domestic) or (412)
902-4203 (international) and asking to join the Amyris, Inc.
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-Market™ technology platform. This Amyris
technology platform leverages state-of-the-art machine learning,
robotics and artificial intelligence, enabling the company to
rapidly bring new innovation to market at commercial scale. Amyris
ingredients are included in over 20,000 products from the world's
top brands, reaching more than 300 million consumers. Amyris also
owns and operates a family of consumer brands that is constantly
evolving to meet the growing demand for sustainable, effective and
accessible products. For more information, please visit
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
SOURCE Amyris, Inc.